Stock ownership · SEC 13F · Q4 2025

PROTAGONIST THERAPEUTICS INC

A breakdown of PROTAGONIST THERAPEUTICS INC's institutional base (CUSIP 74366E102): the holders, the concentration among them, and what changed last quarter.

$706K
Reported value
3
Institutions
100%
Top-5 share

The verdict

$706K of PROTAGONIST THERAPEUTICS INC is reported by 3 institutions as of Q4 2025; ownership is held overwhelmingly by a small core of institutions.

3
institutions hold it
$706K
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 74366E102 · Q4 2025 $1M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-MID

  • VALUE-TRACE $0.7M
  • HOLDERS-FOCUS 3 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-LIGHT 2 new
  • BOOK-MID 7Q history

Read with: Ownership concentration guide - PROTAGONIST THERAPEUTICS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of PROTAGONIST THERAPEUTICS INC
  1. 1
    Seven Fleet Capital Management LP $699K
  2. 2
    Bell Investment Advisors, Inc $7K
  3. 3
    TD Capital Management LLC $349

Top 3 reported holders by value · Q4 2025

Institutional ownership over time

The number of institutions reporting a PROTAGONIST THERAPEUTICS INC position has risen from 2 to 3 over the last 7 quarters of 13F filings.

012345 Q1'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25 3
Distinct 13F filers holding PROTAGONIST THERAPEUTICS INC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 Seven Fleet Capital Management LP 8,000 $699K 98.9%
2 Bell Investment Advisors, Inc 81 $7K 1.0%
3 TD Capital Management LLC 4 $349 0.0%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among PROTAGONIST THERAPEUTICS INC's reported holders for Q4 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q4 2025

New positions (2)

Seven Fleet Capital Management LP $699K
TD Capital Management LLC $349

Complete exits (2)

JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) exited
CIBC Bancorp USA Inc. exited

Frequently Asked Questions

How many institutions hold PROTAGONIST THERAPEUTICS INC?▼
PROTAGONIST THERAPEUTICS INC is held by 3 institutional investors per the latest SEC Form 13F filings as of Q4 2025.
What is the total institutional value of PROTAGONIST THERAPEUTICS INC?▼
Institutions report $706K of PROTAGONIST THERAPEUTICS INC as of Q4 2025.
How concentrated is ownership of PROTAGONIST THERAPEUTICS INC?▼
The top five institutional holders account for 100% of the reported institutional value in PROTAGONIST THERAPEUTICS INC, making ownership held overwhelmingly by a small core of institutions.
Who is the largest institutional holder of PROTAGONIST THERAPEUTICS INC?▼
Seven Fleet Capital Management LP is the largest reported holder of PROTAGONIST THERAPEUTICS INC with $699K across 8,000 shares as of Q4 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.